ACADIA PHARMACEUTICALS INC (ACAD) Total liabilities 2016–2025
ACADIA PHARMACEUTICALS INC (ACAD) total liabilities at each fiscal year-end, per SEC filings.
$336.8MFY2025 · since FY2016: $42.7M → $336.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $336.8M | -26.0% |
| FY2024 | $455.0M | +43.4% |
| FY2023 | $317.2M | +69.3% |
| FY2022 | $187.4M | +17.7% |
| FY2021 | $159.2M | +2.3% |
| FY2020 | $155.6M | +85.1% |
| FY2019 | $84.0M | +37.5% |
| FY2018 | $61.1M | +24.2% |
| FY2017 | $49.2M | +15.2% |
| FY2016 | $42.7M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice